Kate Mahon

5PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 28, 2024
Clinical validation of circulating GDF15/MIC-1 as a marker of response to docetaxel and survival in men with metastatic castration-resistant prostate cancer.

Kate L Mahon, Sarah Im Sutherland, Hui Ming Lin

|May 18, 2023
Genomic Subtypes of Appendiceal Adenocarcinoma: Enough to Guide Clinical Decision Making?

Madeleine C Strach, Kate Mahon, Jorge Barriuso

|Jul 28, 2022
The role of chemotherapy in the treatment of advanced appendiceal cancers: summary of the literature and future directions.

Madeleine C Strach, Sarah Sutherland, Lisa G Horvath

|Apr 25, 2022
GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol).

Ciara Conduit, Blossom Mak, Wenjia Qu

|Feb 20, 2021
Review of systemic chemotherapy in unresectable colorectal peritoneal carcinomatosis.

Udit Nindra, Adel Shahnam, Kate L Mahon

Pageof 1

Frequent Collaborators

2 joint publications

Madeleine C Strach

1 joint publications

Udit Nindra

1 joint publications

Adel Shahnam

1 joint publications

Blossom Mak